00:00 / 00:00
of complete
of complete
of complete
2024
2023
2022
2021
opioid analgesics p. 567
opiod analgesics p. 567
opioid analgesics p. 567
opioid effect on p. 567
opioids for p. 567
opioid withdrawal p. 588
opioid effects p. 567
opioid effects p. 567
opioids for withdrawal p. 567
opioids p. 568
for opioid toxicity p. 247, 567, 588
opioid toxicity p. 567, 588
opioid effect on p. 567
Beers criteria p. 246
intoxication and withdrawal p. 588
pentazocine and p. 568
sleep apnea p. 697
toxicity treatment p. 247
opioid effect p. 567
opiate use during p. 633
opioids for p. 567
opioids p. 568
with opioid analgesics p. 567
Medscape
Medscape
Medscape
Medscape
Medscape
Medscape
Medscape
Medscape
Medscape
Wikipedia
Wikipedia
Wikipedia
Wikipedia
Wikipedia
Wikipedia
Wikipedia
Wikipedia
Wikipedia
Wikipedia
Wikipedia
Opioid agonists are medications used mainly to control acute or chronic pain in particular situations.
Some of them are also used to treat diarrhea and cough. When treating pain, the goal should be to use short-acting opioids at the lowest effective dose for just a few days, and slowly increase their dose only as needed.
As a class, opioids share one thing in common, they bind to opioid receptors in the brain, spinal cord, and gastrointestinal tract.
Some are endogenous, meaning they are produced naturally by the body, like endorphins, short for endogenous morphine.
But others are exogenous, meaning they come from outside the body, like heroin and morphine, which come from the opium poppy; a flowering plant that oozes a milky white liquid.
To understand how opioids work, let’s zoom into a region of the brain tissue that has opioid receptors.
Normally, in the absence of endorphins, inhibitory neurons secrete a neurotransmitter called gamma-aminobutyric acid, or GABA, that prevents nearby neurons from releasing neurotransmitters like dopamine, serotonin, and norepinephrine.
Now, let’s say someone goes to play a rigorous game of badminton. Exercise releases endorphins which activate the three major opioid receptors located on the inhibitory neurons, called the mu, kappa, and delta receptors.
As endorphins bind to these receptors, they block the inhibitory neuron from releasing GABA, allowing the dopamine, serotonin, and norepinephrine secreting neurons to freely unload their neurotransmitters, which then get picked up by another neuron in the same area.
Norepinephrine and serotonin release takes place in pain processing regions of the brain like the thalamus, brainstem, and spinal cord, resulting in a decreased sensitivity to pain.
When dopamine release takes place in reward pathway regions like the ventral tegmental area, nucleus accumbens, and prefrontal cortex, the result is a calming sensation that feels really good.
Opioid full agonists are drugs that bind to and activate opioid receptors in the body. They are used to treat pain and can also produce feelings of euphoria, which has led to their abuse and addiction potential. Examples of opioid agonists include morphine, codeine, and oxycodone.
Mixed agonist-antagonists bind to and activate opioid receptors to a certain extent, but also have the ability to block or inhibit the effects of other opioids. They can also be used to treat pain and may have a lower risk of abuse and addiction compared to full agonists.
Copyright © 2024 Elsevier, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
Cookies are used by this site.
USMLE® is a joint program of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). COMLEX-USA® is a registered trademark of The National Board of Osteopathic Medical Examiners, Inc. NCLEX-RN® is a registered trademark of the National Council of State Boards of Nursing, Inc. Test names and other trademarks are the property of the respective trademark holders. None of the trademark holders are endorsed by nor affiliated with Osmosis or this website.